Tissue Repair Ltd (TRP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tissue Repair Ltd (TRP) has a cash flow conversion efficiency ratio of -0.339x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.01 Million ≈ $-2.84 Million USD) by net assets (AU$11.83 Million ≈ $8.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Tissue Repair Ltd worth for the company's overall valuation and market capitalisation.
Tissue Repair Ltd - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Tissue Repair Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Tissue Repair Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tissue Repair Ltd ranked by their cash flow conversion efficiency. See cash flow to debt ratio of Tissue Repair Ltd to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Octopus Renewables Infra Trust
LSE:ORIT
|
0.039x |
|
C29 Metals Ltd
AU:C29
|
-4.714x |
|
PAVmed Inc
NASDAQ:PAVM
|
-0.035x |
|
Tiphone Mobile Indonesia Tbk
JK:TELE
|
0.000x |
|
Simble Solutions Ltd
AU:SIS
|
1.447x |
|
Juno Minerals Ltd
AU:JNO
|
-0.032x |
|
TwentyFour Select Monthly Income Fund Ltd
LSE:SMIF
|
0.045x |
|
CCH Holdings Ltd Ordinary Shares
NASDAQ:CCHH
|
N/A |
Annual Cash Flow Conversion Efficiency for Tissue Repair Ltd (2020–2025)
The table below shows the annual cash flow conversion efficiency of Tissue Repair Ltd from 2020 to 2025. View TRP live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$13.91 Million ≈ $9.84 Million |
AU$-3.70 Million ≈ $-2.62 Million |
-0.266x | +3.12% |
| 2024-06-30 | AU$18.04 Million ≈ $12.76 Million |
AU$-4.95 Million ≈ $-3.50 Million |
-0.274x | -41.14% |
| 2023-06-30 | AU$21.88 Million ≈ $15.48 Million |
AU$-4.26 Million ≈ $-3.01 Million |
-0.194x | -24.24% |
| 2022-06-30 | AU$25.34 Million ≈ $17.93 Million |
AU$-3.97 Million ≈ $-2.81 Million |
-0.157x | -396.87% |
| 2021-06-30 | AU$27.07 Million ≈ $19.16 Million |
AU$-852.89K ≈ $-603.47K |
-0.032x | +95.15% |
| 2020-06-30 | AU$999.90K ≈ $707.50K |
AU$-649.98K ≈ $-459.91K |
-0.650x | -- |
About Tissue Repair Ltd
Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. The company utilizes Glucoprime technology, an immunogenic active pharmaceutical ingredient that activates macrophages and stimulates immune response for wound healing and skin regeneration. It develops TR-987, a topical … Read more